Published in Nutrition on February 28, 2014
Artemisia santolinifolia enhances glutamatergic neurotransmission in the nucleus of the solitary tract. Neurosci Lett (2014) 0.75
NMDA receptors control vagal afferent excitability in the nucleus of the solitary tract. Brain Res (2014) 0.75
Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report (2008) 19.25
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry (2006) 14.15
The molecular neurobiology of depression. Nature (2008) 6.51
Cell type–specific channelrhodopsin-2 transgenic mice for optogenetic dissection of neural circuitry function. Nat Methods (2011) 4.02
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci U S A (2000) 2.64
Robust pacemaking in substantia nigra dopaminergic neurons. J Neurosci (2009) 2.35
Purinergic and vanilloid receptor activation releases glutamate from separate cranial afferent terminals in nucleus tractus solitarius. J Neurosci (2004) 2.08
Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther (1999) 1.96
Astrocytic control of synaptic NMDA receptors. J Physiol (2007) 1.85
St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol (2001) 1.75
Vanilloid receptors presynaptically modulate cranial visceral afferent synaptic transmission in nucleus tractus solitarius. J Neurosci (2002) 1.43
Mechanism of action of St John's wort in depression : what is known? CNS Drugs (2003) 1.34
Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels. FASEB J (2007) 1.31
Strategies for cellular identification in nucleus tractus solitarius slices. J Neurosci Methods (2004) 1.30
St John's Wort: effect on CYP3A4 activity. Clin Pharmacol Ther (2000) 1.30
Beyond efficacy: the STAR*D trial. Am J Psychiatry (2006) 1.28
Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther (2000) 1.27
Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci (1998) 1.25
TNF-alpha activates solitary nucleus neurons responsive to gastric distension. Am J Physiol Gastrointest Liver Physiol (2000) 1.09
Live-cell imaging methods for the study of vagal afferents within the nucleus of the solitary tract. J Neurosci Methods (2005) 1.09
Metabotropic glutamate receptors inhibit mechanosensitivity in vagal sensory neurons. Gastroenterology (2005) 1.09
Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacopsychiatry (1997) 1.06
Is L-glutamate a neurotransmitter of baroreceptor information in the nucleus of the tractus solitarius? J Pharmacol Exp Ther (1989) 1.06
Current St John's wort research from mode of action to clinical efficacy. Pharmacol Res (2003) 1.04
Strategies for producing faster acting antidepressants. Drug Discov Today (2005) 1.02
Both NMDA and non-NMDA receptors in the NTS participate in the baroreceptor reflex in rats. Am J Physiol (1994) 1.02
Tumor necrosis factor-alpha in the dorsal vagal complex suppresses gastric motility. Neuroimmunomodulation (1996) 1.01
A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts. Phytomedicine (2003) 1.01
Tumor necrosis factor potentiates central vagal afferent signaling by modulating ryanodine channels. J Neurosci (2006) 1.00
LPS-induced suppression of gastric motility relieved by TNFR:Fc construct in dorsal vagal complex. Am J Physiol Gastrointest Liver Physiol (2002) 0.94
Isolation, purity analysis and stability of hyperforin as a standard material from Hypericum perforatum L. J Pharm Pharmacol (1999) 0.94
Hyperforin modulates dendritic spine morphology in hippocampal pyramidal neurons by activating Ca(2+) -permeable TRPC6 channels. Hippocampus (2012) 0.93
Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1. J Pharmacol Exp Ther (1999) 0.91
Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Res (1999) 0.91
Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus. Neurosci Lett (1999) 0.90
TNF(alpha) modulation of visceral and spinal sensory processing. Curr Pharm Des (2005) 0.87
Non-NMDA and NMDA receptors in the synaptic pathway between area postrema and nucleus tractus solitarius. Am J Physiol (1998) 0.87
Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology. J Psychopharmacol (2001) 0.86
St. John's Wort inhibits adipocyte differentiation and induces insulin resistance in adipocytes. Biochem Biophys Res Commun (2009) 0.86
TNF alpha-p55 receptors: medullary brainstem immunocytochemical localization in normal and vagus nerve-transected rats. Brain Res (2004) 0.83
Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort. Pharmacopsychiatry (2001) 0.81
Effects of long-term administration of hypericum extracts on the affinity and density of the central serotonergic 5-HT1 A and 5-HT2 A receptors. Pharmacopsychiatry (1997) 0.80
[What is known about St. John's wort? Phytochemistry and pharmacology]. Pharm Unserer Zeit (2003) 0.79
Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids. J Neurosci (2012) 0.79
The involvement of sodium and calcium ions in the release of amino acid neurotransmitters from mouse cortical slices elicited by hyperforin. Life Sci (2002) 0.76